| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $385K | — | +9.8% |
| SG&A Expense | $275K | — | -18.8% |
| Operating Income | -$659K | — | +4.3% |
| Interest Expense | $4K | — | — |
| Net Income | -$664K | — | -172.2% |
| EPS (Basic) | -$0.00 | — | -100.0% |
| EPS (Diluted) | -$0.00 | — | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9K | -86.7% | +14.3% |
| Current Assets | $20K | -73.7% | -49.6% |
| Total Assets | $1.3M | -6.9% | -11.7% |
| Current Liabilities | $3.1M | +4.5% | +33.9% |
| Total Liabilities | $5.2M | +2.6% | +18.3% |
| Stockholders' Equity | -$3.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$419K | — | -3219.7% |
| Capital Expenditures | $105K | — | +0.0% |
| Investing Cash Flow | -$10K | — | +93.5% |
| Financing Cash Flow | $372K | — | +272.0% |
| Free Cash Flow | -$523K | — | -473.6% |
| -33.4% |